Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Blinatumomab with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive minimal residual disease-negative B-cell precursor acute lymphoblastic leukaemia (new NICE guideline TA1049)
Classification and risk stratification in T-lineage acute lymphoblastic leukemia
The contribution of the monocyte-macrophage lineage to immunotherapy outcomes
Don't break the (blood) bank: can waste be minimized in a whole blood program?
Essential thrombocythemia: a review
The evolution of treatment-free remission
FDA-approved therapies for chronic GVHD
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
Haemophilia (Lancet seminar)
Honing CAR T cells to tackle acute myeloid leukemia
How I diagnose and treat acute infection–associated purpura fulminans
How I manage patients with unexplained cytopenia
How I treat acute myeloid leukemia with differentiation therapy
How I treat patients with AML using azacitidine and venetoclax
How I treat quantitative fibrinogen disorders
How I treat secondary acute myeloid leukemia
How I use maintenance therapy in acute myeloid leukemia
Illustrated capsules from the Advanced Course in Platelet Research
Impact of new medications on the treatment of immune TTP
Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia
Novel treatment strategies for chronic myeloid leukemia
The present and future of CAR T-cell therapy for adult B-cell ALL
Red blood cell transfusion management for people undergoing cardiac surgery for congenital heart disease (new Cochrane intervention review)
The United Kingdom Infected Blood Inquiry: its findings and lessons for the future of transfusion
American Journal of Surgery (Feb); Blood (20th Feb - 10th Apr); Cochrane Library (Mar-Apr); JAMA (Feb); Lancet, The (Mar); NICE website (Mar); Research and Practice in Thrombosis and Haemostasis (Feb)
Acute promyelocytic leukemia: long-term outcomes from the HARMONY project
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban (updated NICE guideline TA697)
β-Thalassemia minor is associated with high rates of worsening anemia in pregnancy
Building the future management of follicular lymphoma with T-cell–redirecting strategies
Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria
The current landscape of frontline large B-cell lymphoma trials
Current myeloproliferative neoplasm scoring systems for clinical practice
Frontline management of mantle cell lymphoma
High-risk MCL: recognition and treatment
How I treat/manage:
Management of iron overload: lessons from transfusion-dependent hemoglobinopathies
Menin inhibitors in the treatment of acute myeloid leukemia
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19
Transfusion of blood and blood products for the management of postpartum haemorrhage (new Cochrane intervention review)
Treatment of relapsed/refractory MCL
Unraveling MCL biology to understand resistance and identify vulnerabilities
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease (new NICE guideline TA1035
Blood (Jan-13th Feb); Cochrane Library (Feb); Journal of Pain and Symptom Management (Jan); NICE website (Jan-Feb)
Are we there yet? CAR-T therapy in multiple myeloma
Blood coagulation factor IX: structural insights impacting hemophilia B therapy
Cell salvage for the management of postpartum haemorrhage (new Cochrane review)
Chimeric antigen receptor T-cell therapy for haematological malignancies
Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy
Coagulation factor VIII: biological basis of emerging hemophilia A therapies
Dialysis for chronic kidney failure: a review
DLBCL: who is high risk and how should treatment be optimized?
Effect and safety of intravenous iron compared to oral iron for treatment of iron deficiency anaemia in pregnancy (new Cochrane review)
See also: The power and perils of large language models in haematology
Haemodiafiltration versus haemodialysis for kidney failure
The high-grade B-cell lymphomas: double hit and more
Paediatric relapsed acute leukaemia: curative intent chemotherapy improves quality of life
Peripheral T-cell lymphoma: are all patients high risk?
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm
Platelet generation in vivo and in vitro
Primary large B-cell lymphomas of immune-privileged sites
RNA-loaded nanoparticles for the treatment of hematological cancers
Sequencing of therapy for patients with diffuse large B-cell lymphoma in the era of novel drugs
T-cell lymphomas in recipients of CAR-T cells: assessing risks and causalities
Therapeutic strategies targeting aberrant RNA splicing in myeloid malignancies
Treatment for women with postpartum iron deficiency anaemia (updated Cochrane review)
Advanced Drug Delivery Reviews (Nov); Blood (Nov-Dec); BMJ Supportive and Palliative Care (Nov); British Journal of Haematology (Nov-Dec); Cochrane Library (Dec); JAMA (Nov); Lancet, The (Nov)
The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.